These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1407599)

  • 61. Intrathecal baclofen for severe spasticity: five years experience.
    Stewart-Wynne EG; Silbert PL; Buffery S; Perlman D; Tan E
    Clin Exp Neurol; 1991; 28():244-55. PubMed ID: 1821835
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective posterior rhizotomy and intrathecal baclofen for the treatment of spasticity.
    von Koch CS; Park TS; Steinbok P; Smyth M; Peacock WJ
    Pediatr Neurosurg; 2001 Aug; 35(2):57-65. PubMed ID: 11549915
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrathecal baclofen for spasticity in primary lateral sclerosis.
    Teive HA
    J Neurol; 2007 Feb; 254(2):261. PubMed ID: 17260176
    [No Abstract]   [Full Text] [Related]  

  • 66. [Intrathecal baclofen. Experimental and pharmacokinetic studies].
    Sallerin B; Lazorthes Y
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):271-5. PubMed ID: 12746702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
    Otero-Romero S; Sastre-Garriga J; Comi G; Hartung HP; Soelberg Sørensen P; Thompson AJ; Vermersch P; Gold R; Montalban X
    Mult Scler; 2016 Oct; 22(11):1386-1396. PubMed ID: 27207462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.
    Zahavi A; Geertzen JH; Middel B; Staal M; Rietman JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1553-7. PubMed ID: 15489386
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is the antispastic action of baclofen mediated by GABAB receptors? GABAB receptors and spasticity.
    Wüllner U; Klockgether T
    Trends Pharmacol Sci; 1990 Mar; 11(3):103. PubMed ID: 1966568
    [No Abstract]   [Full Text] [Related]  

  • 70. Baclofen and tricyclic antidepressants: possible interaction.
    Silverglat MJ
    JAMA; 1981 Oct; 246(15):1659. PubMed ID: 7277640
    [No Abstract]   [Full Text] [Related]  

  • 71. Pharmacotherapy of multiple sclerosis: current status.
    Rudick RA; Goodkin DE; Ransohoff RM
    Cleve Clin J Med; 1992; 59(3):267-77. PubMed ID: 1516215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Update on multiple sclerosis therapy.
    Mitchell G
    Med Clin North Am; 1993 Jan; 77(1):231-49. PubMed ID: 7678315
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and pharmacokinetic aspects of high dose oral baclofen therapy.
    Aisen ML; Dietz MA; Rossi P; Cedarbaum JM; Kutt H
    J Am Paraplegia Soc; 1992 Oct; 15(4):211-6. PubMed ID: 1431867
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Marijuana may lessen spasticity of MS.
    Check WA
    JAMA; 1979 Jun; 241(23):2476. PubMed ID: 439328
    [No Abstract]   [Full Text] [Related]  

  • 75. Neuropathology of subarachnoid phenol-glycerin.
    Pedersen E; Reske-Nielsen E
    Acta Neuropathol; 1965 Oct; 5(1):112-6. PubMed ID: 5886193
    [No Abstract]   [Full Text] [Related]  

  • 76. Baclofen for spasticity.
    Landau WM; Feldman RG
    Neurology; 1992 Oct; 42(10):2056. PubMed ID: 1407599
    [No Abstract]   [Full Text] [Related]  

  • 77. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
    Hoogstraten MC; van der Ploeg RJ; vd Burg W; Vreeling A; van Marle S; Minderhoud JM
    Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Treatment of spasticity by intrathecal baclofen treatment].
    Helén P; Kuurne T
    Duodecim; 1993; 109(14):1251-5. PubMed ID: 8062701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.